THIP Academy recognised for evidence-based vaccination education as platform expands courses on adult, paediatric and HPV vaccination
The trial met its primary endpoint of recurrence-free survival and a key secondary endpoint of distant metastasis-free survival, marking what the companies describe as the first positive Phase 3 readout
The company said corrective action was already initiated during the course of the inspection itself, and a formal response will be submitted to the US regulator within the stipulated timeline
The platform is designed to provide continuous, objective monitoring of Parkinson’s symptoms and treatment response, including bradykinesia, dyskinesia, tremor, sleep, motor fluctuations, gait and medication compliance
Visits UNICEF-supported programme in Maharashtra protecting children affected by seasonal migration through family- and community-based care
The agreement marks another step in Lupin’s strategy to expand its specialty ophthalmology business through VISUfarma, following the company’s strategic acquisition of the eye-care specialist
The company operates a CRO Plus model, combining clinical execution with strategic advisory and central laboratory capabilities
The partnership strengthens Mankind Pharma’s diabetes care and injectable portfolio, expanding its range of advanced insulin therapies for the Indian market
Six-day residential programme will provide researchers, policymakers and industry professionals with comprehensive training in vaccine development, clinical trials, regulatory approvals, manufacturing and quality compliance
The company also turned profitable at the standalone level, reporting PAT of Rs. 12 crore, against a loss of Rs. 3 crore in Q1 FY26
IQGEN-X Pharma is engaged in formulation development of oral solids, sterile injectables and ophthalmic solutions for regulated and semi-regulated markets.
The platform will facilitate continuous medical education, scientific discussions and exchange of real-world clinical experiences among healthcare professionals
Henlius will hold on to commercial rights within mainland China, Hong Kong, Macau and Taiwan, while Sandoz takes charge everywhere else globally
The company expects the US Food and Drug Administration could approve dersimelagon for EPP and XLP as early as 2027, subject to regulatory review
The fund will be managed by Aditya Khemani, Head of Equity & Fund Manager, Invesco Mutual Fund, and will be benchmarked against the BSE Healthcare TRI
All equity shares of Inzpera held by Cipla will simply stand cancelled upon the scheme taking effect, with no allotment of Cipla shares to any external shareholders
Operating revenue for the quarter grew a modest 3.93% year-on-year to Rs. 193.81 crore
Following the creation of the revised security, the pledge on the 28,280 BSVL shares, which had been maintained in favour of the debenture trustee on behalf of NCD holders, was released on August 17, 2026
Following the acquisition, Hearzap’s network will expand to 420 centres across India, supported by more than 1,000 service providers
The regulatory milestone strengthens the company’s bid to develop ACI-7104 as a potential treatment for Parkinson’s
Subscribe To Our Newsletter & Stay Updated
